{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:40:22Z","timestamp":1770748822218,"version":"3.50.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T00:00:00Z","timestamp":1708819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jacep.2024.02.021","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T20:01:49Z","timestamp":1712779309000},"page":"1021-1033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm"],"prefix":"10.1016","volume":"10","author":[{"given":"Jeremy N.","family":"Ruskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-2871","authenticated-orcid":false,"given":"A. John","family":"Camm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Dufton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7057-4964","authenticated-orcid":false,"given":"Anderson C.","family":"Woite-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ype","family":"Tuininga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Badings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas S.S.G.","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Oosterhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaf F.M.","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle C.","family":"Van Gelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Nuyens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schellings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Maupas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Belardinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2024.02.021_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib2","article-title":"Emergency department visits for atrial fibrillation in the United States: trends in admission rates and economic burden from 2007 to 2014","volume":"7","author":"Rozen","year":"2018","journal-title":"J\u00a0Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"10.1016\/j.jacep.2024.02.021_bib3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.amjcard.2013.07.005","article-title":"Predictors of regional variations in hospitalizations following emergency department visits for atrial fibrillation","volume":"112","author":"Barrett","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib4","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.amjcard.2017.08.017","article-title":"Emergency department, hospital inpatient, and mortality burden of atrial fibrillation in the United States, 2006 to 2014","volume":"120","author":"Jackson","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.02.021_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FJC.0000000000000804","article-title":"Pulmonary delivery of antiarrhythmic drugs for rapid conversion of new-onset atrial fibrillation","volume":"75","author":"Verrier","year":"2020","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacep.2024.02.021_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010204","article-title":"Open-Label, multicenter study of flecainide acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm","volume":"15","author":"Crijns","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib8","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.hrthm.2018.06.036","article-title":"Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model","volume":"15","author":"Verrier","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.02.021_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0000000000000605","article-title":"Comparative pharmacokinetic and electrocardiographic effects of intratracheal and intravenous administration of flecainide in anesthetized pigs","volume":"72","author":"Stocco","year":"2018","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacep.2024.02.021_bib10","series-title":"FLECAINIDE ACETATE tablet. Package insert","year":"2020"},{"key":"10.1016\/j.jacep.2024.02.021_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00228-015-1832-0","article-title":"Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide","volume":"71","author":"Tamargo","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacep.2024.02.021_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","article-title":"Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation","volume":"30","author":"Clark","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9149(97)89297-1","article-title":"Effect of an irregular ventricular rhythm on cardiac output","volume":"78","author":"Daoud","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib14","doi-asserted-by":"crossref","first-page":"n991","DOI":"10.1136\/bmj.n991","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacep.2024.02.021_bib15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early\u00a0rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2024.02.021_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-5273(02)00467-9","article-title":"Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"87","author":"Khan","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/oxfordjournals.eurheartj.a062553","article-title":"Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens","volume":"9","author":"Crijns","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.02.021_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9149(94)90915-6","article-title":"Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide","volume":"74","author":"Capucci","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/heart.84.1.37","article-title":"Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation","volume":"84","author":"Alp","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2024.02.021_bib20","first-page":"1200","article-title":"Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials","volume":"23","author":"Ibrahim","year":"2021","journal-title":"EP Eur"},{"key":"10.1016\/j.jacep.2024.02.021_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jemermed.2017.11.016","article-title":"Intravenous flecainide for emergency department management of acute atrial fibrillation","volume":"54","author":"Markey","year":"2018","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.jacep.2024.02.021_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ahj.2004.08.012","article-title":"Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the\u00a0AFFIRM study","volume":"149","author":"Curtis","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2024.02.021_bib23","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/0735-1097(90)90326-K","article-title":"The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"16","author":"Suttorp","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib24","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.hrthm.2021.04.007","article-title":"Flecainide-induced QRS complex widening correlates with negative inotropy","volume":"18","author":"Evangelista","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2024.02.021_bib25","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/01.CIR.84.4.1808","article-title":"Proarrhythmic effects of flecainide. Experimental evidence for increased susceptibility to reentrant arrhythmias","volume":"84","author":"Brugada","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.02.021_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2165\/00044011-199713060-00005","article-title":"Flecainide-induced increase in QRS duration and proarrhythmia during exercise","volume":"13","author":"Bordier","year":"1997","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacep.2024.02.021_bib27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.RES.57.4.578","article-title":"Lidocaine\u2019s negative inotropic and antiarrhythmic actions. Dependence on shortening of action potential duration and reduction of intracellular sodium activity","volume":"57","author":"Sheu","year":"1985","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2024.02.021_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2021.05.007","article-title":"Mechanisms of flecainide induced negative inotropy: an in silico study","volume":"158","author":"Yang","year":"2021","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2024.02.021_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/hrt.48.2.140","article-title":"Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man","volume":"48","author":"Hellestrand","year":"1982","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacep.2024.02.021_bib30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.hrthm.2006.05.023","article-title":"Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval","volume":"3","author":"Indik","year":"2006","journal-title":"Heart Rhythm"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24001646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24001646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T23:21:00Z","timestamp":1728688860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24001646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405500X24001646"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.02.021","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}